Intra Versus Extra-thoracic Oscillations in Chronic Obstructive Pulmonary Disease
1 other identifier
interventional
60
1 country
1
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is the fourth-leading cause of death. It is a progressive illness that requires life-long treatment.Promoting airway clearance (AC) using mucolytics together with airway clearance techniques (ACTs) form the basis for pulmonary therapy in COPD care.Therefore, new airway clearance modalities are required to decrease the detrimental effects of accumulated secretions in COPD. One of the devices used in AC is the high frequency chest wall oscillation (The Vest). HFCWO involves the use of an inflatable vest/jacket that covers the chest and is attached to an air pulse-generating compressor which rapidly inflates and deflates the vest, producing oscillations to the chest wall of 5-25 Hz. Another new airway clearance modality is oscillating positive expiratory pressure(Quake) which combines PEP therapy with high frequency oscillations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 18, 2019
CompletedFirst Posted
Study publicly available on registry
March 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2019
CompletedAugust 30, 2023
August 1, 2023
1.5 years
March 18, 2019
August 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Pulmonary function test (spirometry)
* it measure ventilatory functions. * Then the patients sat comfortably and upright while putting the nose clip and relax. * The patient was asked to inhale as deeply as possible, hold the breath, and then inserted the mouthpiece carefully into the mouth. * The patient held the mouthpiece tightly between the lips, and kept tongue down. * The patient was asked to exhale for as long as possible and blow for at least 6 seconds.
Before and 6 weeks
Secondary Outcomes (1)
impulse oscillometry
before and 6 weeks
Study Arms (2)
Vest arm
EXPERIMENTALhigh frequency chest wall oscillation vest performed 4 times per week for 6 successive weeks for 30 patients
Quake arm
EXPERIMENTALVibratory positive expiratory pressure quake performed 4 times per week for 6 successive weeks for 30 patients
Interventions
Oscillations applied extra thoracic through vest device aiming for airway clearance
Oscillation introduced intrathoracic through quake device through placing quake in mouth and ordering patient to breathing to move secretions
Eligibility Criteria
You may qualify if:
- All patients were diagnosed by chest physician based on the modified criteria defined in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2017.
- All patients were diagnosed as COPD for at least two years.
- All Patients must use their prescribed medications.
You may not qualify if:
- All patients that had one of the following were excluded from the study. History of osteoporosis, significant gastro-esophageal reflux, hiatus hernia. Recent acute cardiac event (6 weeks) or congestive cardiac failure. Any significant musculoskeletal disorders. Presence of active hemoptysis Presence of malignant disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of physical therapy
Dokki, Giza Governorate, 12613, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nagwa M Badr, Professor
Professor physical therapy at Cairo university
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 18, 2019
First Posted
March 21, 2019
Study Start
November 1, 2017
Primary Completion
May 1, 2019
Study Completion
May 30, 2019
Last Updated
August 30, 2023
Record last verified: 2023-08